Todays Report: Today, Insulet Corp. (PODD) PT Set at $39.00 by Canaccord Genuity

Today, Insulet Corp. (PODD) PT Set at $39.00 by Canaccord Genuity

Insulet Corp. (NASDAQ:PODD) has been given a $39.00 price target by equities researchers at Canaccord Genuity in a report released on Sunday. The firm currently has a “hold” rating on the stock. Canaccord Genuity’s price objective suggests a potential upside of 7.00% from the stock’s current price.

A number of other equities research analysts have also recently weighed in on PODD. Jefferies Group raised their price target on Insulet Corp. from $41.00 to $45.00 and gave the company a “buy” rating in a report on Thursday, August 4th. Zacks Investment Research raised Insulet Corp. from a “hold” rating to a “buy” rating and set a $49.00 price target for the company in a report on Tuesday, August 9th. BTIG Research raised Insulet Corp. from a “neutral” rating to a “buy” rating and set a $42.00 price target for the company in a report on Friday, November 4th. JPMorgan Chase & Co. reissued a “hold” rating and issued a $38.00 target price on shares of Insulet Corp. in a research note on Wednesday, August 17th. Finally, B. Riley assumed coverage on Insulet Corp. in a research note on Sunday, October 2nd. They issued a “neutral” rating and a $46.00 target price for the company. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Insulet Corp. presently has a consensus rating of “Buy” and a consensus target price of $42.15.

Insulet Corp. (NASDAQ:PODD) traded down 0.57% on Friday, hitting $36.45. The stock had a trading volume of 124,543 shares. Insulet Corp. has a 1-year low of $23.94 and a 1-year high of $45.60. The firm’s market cap is $2093.18 billion. The firm’s 50-day moving average price is $37.35 and its 200-day moving average price is $36.38.

Insulet Corp. (NASDAQ:PODD) last announced its quarterly earnings data on Thursday, November 3rd. The company reported ($0.05) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.04. Insulet Corp. had a negative return on equity of 87.46% and a negative net margin of 12.95%. The company earned $94.90 million during the quarter, compared to the consensus estimate of $89.75 million. During the same quarter last year, the company earned ($0.33) EPS. The company’s quarterly revenue was up 32.5% on a year-over-year basis. On average, equities research analysts predict that Insulet Corp. will post ($0.37) earnings per share for the current year.

A number of hedge funds have recently modified their holdings of PODD. FMR LLC increased its stake in shares of Insulet Corp. by 112.8% in the second quarter. FMR LLC now owns 6,025,467 shares of the company’s stock worth $182,210,000 after buying an additional 3,193,967 shares during the last quarter. Capital Research Global Investors increased its stake in shares of Insulet Corp. by 0.7% in the third quarter. Capital Research Global Investors now owns 5,175,033 shares of the company’s stock worth $211,866,000 after buying an additional 37,000 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Insulet Corp. by 3.1% in the second quarter. Vanguard Group Inc. now owns 4,184,980 shares of the company’s stock worth $126,553,000 after buying an additional 124,551 shares during the last quarter. BlackRock Fund Advisors increased its stake in shares of Insulet Corp. by 2.7% in the third quarter. BlackRock Fund Advisors now owns 1,693,722 shares of the company’s stock worth $69,341,000 after buying an additional 43,781 shares during the last quarter. Finally, Daruma Capital Management LLC increased its stake in shares of Insulet Corp. by 12.7% in the first quarter. Daruma Capital Management LLC now owns 1,483,179 shares of the company’s stock worth $49,182,000 after buying an additional 166,639 shares during the last quarter.

About Insulet Corp.

Related posts

Leave a Comment